Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly ...
In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and ...
The pharmacologic agents most often prescribed for patients with AR include oral H 1-antihistamines, intranasal or intraocular H 1-antihistamines, intranasal corticosteroids, nasal decongestants, ...
Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...
Oral second-generation antihistamines are considered first-line therapy for allergic rhinitis but are not indicated for nonallergic vasomotor rhinitis. 1 Intranasal antihistamines can also be ...
Allergic rhinitis is a common, chronic, and often debilitating condition that impacts approximately 500 million people globally 1, putting these patients at greater risk for developing allergic asthma ...
Though they’re separate conditions, allergic rhinitis and asthma are both atopic diseases. Allergies can trigger asthma, and having asthma can increase your risk for allergic rhinitis. Allergic ...
Patients with AR experience prolonged symptoms and inadequate care before accessing AIT, often due to misdiagnosis and limited specialist access. Despite multiple pharmacologic therapies, sustained ...
Please provide your email address to receive an email when new articles are posted on . Among patients with allergic rhinitis (AR), misdiagnosis and suboptimal therapeutic selection in the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results